Abstract:We present a very rare case of tophaceous gout of the middle ear causing conductive hearing loss, with special emphasis on Computed Tomography presentation.
“…The sex ratio was 1/1 and the pathology is more frequent for patients over 55-years-old. The major clinical symptom was a simple progressive hearing loss ( Gargula et al., 2019 ). Abnormal otoscopy occurred in 7 out of 8 patients ( Mutlu et al., 2016 ) with 50% of white sclerotic plaque under the normal tympanic membrane.…”
Gout is the most common cause of monoarthritis in men occurring classically in the great toe and the knee. Extra-articular gout manifestations are rare. Only a few cases of head and neck urate crystals deposits have been described in the literature. Precipitations in the middle ear cause conductive hearing loss with common otoscopic anomalies and difficult imaging diagnosis.
We report a case of a healthy 58-years-old man with a middle ear urate deposit causing a progressive hearing loss as the very first symptom of gout. The nature of the deposit was unsure on computer tomography (CT) due to atypical density. The final diagnosis was revealed after surgical procedure and histologic examination.
A review of the literature is also presented. Seven cases of middle ear urate deposit as the first symptom of gout were found and compared.
Progressive conductive hearing loss in middle-aged patients with abnormal otoscopy and middle ear atypical density mass on CT scan must lead to a minimal surgical procedure with a histologic examination to exclude urate crystals deposits.
“…The sex ratio was 1/1 and the pathology is more frequent for patients over 55-years-old. The major clinical symptom was a simple progressive hearing loss ( Gargula et al., 2019 ). Abnormal otoscopy occurred in 7 out of 8 patients ( Mutlu et al., 2016 ) with 50% of white sclerotic plaque under the normal tympanic membrane.…”
Gout is the most common cause of monoarthritis in men occurring classically in the great toe and the knee. Extra-articular gout manifestations are rare. Only a few cases of head and neck urate crystals deposits have been described in the literature. Precipitations in the middle ear cause conductive hearing loss with common otoscopic anomalies and difficult imaging diagnosis.
We report a case of a healthy 58-years-old man with a middle ear urate deposit causing a progressive hearing loss as the very first symptom of gout. The nature of the deposit was unsure on computer tomography (CT) due to atypical density. The final diagnosis was revealed after surgical procedure and histologic examination.
A review of the literature is also presented. Seven cases of middle ear urate deposit as the first symptom of gout were found and compared.
Progressive conductive hearing loss in middle-aged patients with abnormal otoscopy and middle ear atypical density mass on CT scan must lead to a minimal surgical procedure with a histologic examination to exclude urate crystals deposits.
“…[1][2][3] Although conductive hearing loss due to a middle ear mass is common, a tophus in the middle ear is an uncommon cause of a middle ear mass. [3][4][5][6][7][8] The low incidence combined with the absence of clinical manifestations of gout or hyperuricemia in all known cases, including in this patient, explains why tophaceous gout in the middle ear is often misidentified as osteoma, cholesteatoma, or tympanosclerosis. 3,6,7 This emphasizes the importance of considering the diagnosis of a tophus in patients with conductive hearing loss and a mass in the middle ear.…”
A 65-year-old patient with a history of myocardial infarction, sleep apnea, Meniere disease, and congenital cataract presents with left-sided hearing loss during the past 6 months without evident cause. What is your diagnosis?
“…PTA revealed a right CHL with a 50 dB ABG, High-resolution CT on right temporal bone revealed calcified mass at the anterior part of the tympanic cleft. Pathological examination of excised mass revealed gouty tophi in ME [20] . According to V.N.G test battery results, Dix-Hallpike test revealed that 9 subjects [22.5%] in the study group presented with peripheral vertigo [BPPV], this percentage was in agreement with Lin et al [9] ; they found 21% of total number of cases of BPPV to have hyperuricemia.…”
Section: Discussionmentioning
confidence: 99%
“…I-Spontaneous nystagmus: Subject was asked to sit with head upright and the back is supported, spontaneous nystagmus observed in complete absence of any visual fixation. Minimum observation period is 30 seconds.II-Gaze test: Subject was asked to fix his vision on the light bar, 20-degree eccentric position vertical and horizontal and the eye is kept in position for20-30 seconds. III-Oculomotor tests: Subject was seated on test chair 1.5 meters from the center of the T.V.…”
Background: Hyperuricemia is a common biochemical disturbance in which serum concentration of uric acid exceeds the normal values which is 7.0 mg/dl in men and more than 6.0 mg/dl in women leading to deposition of monosodium urate [MSU] crystals in joints and soft tissues resulting in inner ear functions affection. Aim of the work: To elaborate the effect of hyperuricemia on the peripheral hearing as well as peripheral vestibular functions. Subjects and Methods: This study included 40 subjects with hyperuricemia and 40 healthy controls. Participants underwent serum uric acid assay, full history taking, basic audiological evaluation and vestibular evaluation. Results: 37[92.5%] hyperuricemic subjects had normal peripheral hearing sensitivity, only 3[7.5%] had mild high frequencies sensori-neural hearing loss [SNHL] at 8 kHz. 31[77.5%] Hyperuricemic patients had normal peripheral vestibular functions, only 9[22.5%] subjects had BPPV; They also had higher serum uric acid [SUA] level. No correlation between duration of hyperuricemia and occurrence of BPPV. Conclusions: The hyperuricemic subjects had a significant higher incidence of BPPV. Other investigations to detect early and subtle changes in cochlear function of hyperuricemic subjects were recommended.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.